NDC 68180-801
Lapatinib
Lapatinib
Lapatinib is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Lapatinib Ditosylate.
| Product ID | 68180-801_50d0dd0c-7682-43d0-aa1b-ca26e9181aee |
| NDC | 68180-801 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lapatinib |
| Generic Name | Lapatinib |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-09-29 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203007 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | LAPATINIB DITOSYLATE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |